0B68 Ertel, Adam - Thomas Jefferson University - Thomas Jefferson University

Adam Ertel, PhD

Contact Dr. Ertel

Kimmel Cancer Center
233 S. Tenth Street, Suite 1009
Philadelphia, PA 19107

(215) 503-7452
(215) 503-9142 fax

Most Recent Peer-reviewed Publications

  1. A community effort to assess and improve drug sensitivity prediction algorithms
  2. A community computational challenge to predict the activity of pairs of compounds
  3. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines
  4. The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness
  5. Retinoblastoma protein potentiates the innate immune response in hepatocytes: Significance for hepatocellular carcinoma
  6. The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer
  7. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation
  8. Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint
  9. Retinoblastoma protein potentiates the innate immune response in hepatocytes: 05B4 Significance for hepatocellular carcinoma
  10. Functional significance of macrophage-derived exosomes in inflammation and pain
  11. Cyclin D1 induction of dicer governs microRNA processing and expression in breast cancer
  12. Cancer cell proliferation through cyclin D1
  13. Global profiling of prolactin-modulated tran 0BA2 scripts in breast cancer in vivo
  14. STAT5A/B gene locus undergoes amplification during human prostate cancer progression
  15. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer
  16. Dachshund binds p53 to block the growth of lung adenocarcinoma cells
  17. Aberrant BAF57 signaling facilitates prometastatic phenotypes
  18. Erratum: ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice (J Clin Invest. (2013) 123:5 (2332) 10.1172/JCI70042)
  19. Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3
  20. The complex transcriptional landscape of the anucleate human platelet